Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainANK

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

3.33e-092515610SM00248
DomainANK_REPEAT

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

3.59e-092535610PS50088
DomainAnkyrin_rpt-contain_dom

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

3.73e-092545610IPR020683
DomainANK_REP_REGION

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

3.73e-092545610PS50297
DomainAnkyrin_rpt

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

5.02e-092625610IPR002110
Domain-

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH KRIT1

4.88e-082485691.25.40.20
DomainAnk_2

POTEB3 POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH

2.39e-07215568PF12796
DomainAnk

POTEE POTEM POTEF POTEG OSBPL1A POTEH POTEB KRIT1

3.74e-07228568PF00023
Domainzf-C2H2_jaz

ZNF385D HIVEP2 ZNF385B

3.78e-0522563PF12171
DomainZnf_C2H2_jaz

ZNF385D HIVEP2 ZNF385B

3.78e-0522563IPR022755
DomainZnf_C2H2_matrin

ZNF385D ZNF385B

5.72e-0412562IPR000690
DomainActin_CS

POTEE POTEF

1.03e-0316562IPR004001
DomainACTINS_2

POTEE POTEF

1.17e-0317562PS00432
DomainActin/actin-like_CS

POTEE POTEF

1.31e-0318562IPR020902
DomainZF_MATRIN

ZNF385D ZNF385B

1.31e-0318562PS50171
DomainACTINS_ACT_LIKE

POTEE POTEF

1.46e-0319562PS01132
DomainZnF_U1

ZNF385D ZNF385B

3.40e-0329562SM00451
DomainZnf_U1

ZNF385D ZNF385B

3.40e-0329562IPR003604
DomainActin

POTEE POTEF

3.88e-0331562IPR004000
DomainActin

POTEE POTEF

3.88e-0331562PF00022
DomainACTIN

POTEE POTEF

3.88e-0331562SM00268
DomainZnf_C2H2-like

ZNF385D ZNF14 BCL11B HIVEP2 CTCF ZFP64 ZNF385B

9.38e-03796567IPR015880
DomainZnf_C2H2

ZNF385D ZNF14 BCL11B HIVEP2 CTCF ZFP64 ZNF385B

9.94e-03805567IPR007087
DomainZnF_C2H2

ZNF385D ZNF14 BCL11B HIVEP2 CTCF ZFP64 ZNF385B

1.01e-02808567SM00355
Pubmed

Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.

POTEM POTEG POTEB2 POTEH POTEB

8.41e-14661517171436
Pubmed

Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.

POTEB3 POTEE POTEG POTEH POTEB

2.94e-13761515276201
Pubmed

The Vertebrate Genome Annotation browser 10 years on.

CFAP47 POTEB3 POTEE POTEM POTEF POTEG POTEB2 POTEH POTEB

1.23e-1116361924316575
Pubmed

POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.

POTEB3 POTEB2 POTEH POTEB

5.96e-10861412475935
Pubmed

Identification of a novel actin isoform in hepatocellular carcinoma.

POTEE POTEM POTEF POTEG

1.15e-081561416824795
Pubmed

Identification and characterization of TSAP, a novel gene specifically expressed in testis during spermatogenesis.

POTEM POTEH POTEB

2.05e-08461317342726
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

PCF11 POTEE MYH3 ACSM3 POTEF CNTRL UBR4 SCN9A NUP98 KDR MYOM2 SKAP2 RYR2

1.04e-061442611335575683
Pubmed

A primate-specific POTE-actin fusion protein plays a role in apoptosis.

POTEE POTEF

3.03e-06261219669888
Pubmed

Cystic Hygroma: A Preliminary Genetic Study and a Short Review from the Literature.

KDR KRIT1

3.03e-06261230475086
Pubmed

Evolution and expression of chimeric POTE-actin genes in the human genome.

POTEE POTEF

9.07e-06361217101985
Pubmed

Personalized copy number and segmental duplication maps using next-generation sequencing.

POTEB3 POTEB

3.02e-05561219718026
Pubmed

Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.

POTEE POTEM

1.08e-04961216364570
Pubmed

Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.

KDR KRIT1

1.65e-041161219151727
Pubmed

Dual effect of CTCF loss on neuroprogenitor differentiation and survival.

BCL11B CTCF

1.97e-041261224553927
Pubmed

Altered proliferative ability of neuronal progenitors in PlexinA1 mutant mice.

BCL11B KDR

2.72e-041461225975775
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

POTEE VPS18 BCL11B SERBP1 POTEF NUP98

2.80e-0451361625798074
Pubmed

Klf5 regulates muscle differentiation by directly targeting muscle-specific genes in cooperation with MyoD in mice.

MYH3 MYOM2

3.13e-041561227743478
Pubmed

Vascular-Derived Vegfa Promotes Cortical Interneuron Migration and Proximity to the Vasculature in the Developing Forebrain.

BCL11B KDR

3.13e-041561229901792
Pubmed

Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections.

BCL11B KDR

5.08e-041961223395374
Pubmed

Blimp1/Prdm1 governs terminal differentiation of endovascular trophoblast giant cells and defines multipotent progenitors in the developing placenta.

MYH3 KDR

5.08e-041961222987638
Pubmed

Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.

BCL11B PCK2

5.63e-042061232294449
Pubmed

Murine embryonic stem cell-derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets.

HOXC5 BCL11B

7.48e-042361220089898
Pubmed

Cranial neural crest deletion of VEGFa causes cleft palate with aberrant vascular and bone development.

TGFBR3 KDR

7.48e-042361225759071
Pubmed

Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

KDR KRIT1

8.15e-042461220371769
Pubmed

A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.

SERBP1 NUP98 FAM9A SKAP2 PCK2

9.61e-0443161533660365
Pubmed

Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in sphingolipid biosynthesis during skin development.

SPTLC3 BCL11B

1.03e-032761223096701
Pubmed

Conditionals by inversion provide a universal method for the generation of conditional alleles.

SCN9A KDR

1.03e-032761223918385
Pubmed

A census of human transcription factors: function, expression and evolution.

ZNF14 HOXC5 BCL11B HIVEP2 CTCF NFIL3 ZBED2

1.03e-0390861719274049
Pubmed

A genetic linkage map of mouse chromosome 2 extending from thrombospondin to paired box gene 1, including the H3 minor histocompatibility complex.

CHGB PCK2

1.19e-03296128617512
Pubmed

Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.

MYH3 MYOM2

1.36e-033161222282597
Pubmed

Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.

POTEE PCK2

1.45e-033261231815296
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

SYNJ1 UBR4 SCN9A ZNF385B KRIT1

1.48e-0347561531040226
Pubmed

BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.

VPS18 ATRIP SYNJ1 HEATR5B

1.60e-0328561434369648
Pubmed

Gene-environment interactions and obesity traits among postmenopausal African-American and Hispanic women in the Women's Health Initiative SHARe Study.

ZNF385D SPTLC3

1.73e-033561223192594
Pubmed

Genome-wide association study of selenium concentrations.

ZNF14 MYOM2

1.73e-033561225343990
InteractionPOTEG interactions

POTEF POTEG POTEH

5.42e-0612603int:POTEG
InteractionPOTEC interactions

POTEB3 POTEF POTEG

7.02e-0613603int:POTEC
InteractionPOTEH interactions

POTEG POTEH

8.72e-062602int:POTEH
InteractionMOGAT1 interactions

POTEE SERBP1

5.21e-054602int:MOGAT1
GeneFamilyAnkyrin repeat domain containing|POTE ankyrin domain containing

POTEE POTEM POTEF POTEG POTEB2 POTEH POTEB

1.13e-1613367685
GeneFamilyAnkyrin repeat domain containing

POTEE POTEM POTEF POTEG OSBPL1A POTEB2 POTEH POTEB KRIT1

8.17e-10242369403
CoexpressionRAO_BOUND_BY_SALL4_ISOFORM_B

OR5P2 POTEB3 POTEE POTEM POTEF ZFP64 POTEG POTEB2 SKAP2 POTEH POTEB

9.33e-085846111MM1080
CoexpressionGSE3982_DC_VS_MAC_UP

PCF11 SPTLC3 MYH3 NFIL3 UBR4 OSBPL1A LRRFIP2

4.17e-07200617M5458
CoexpressionGSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN

MED15 MYH3 SYNJ1 UBR4 KDR MINAR1

7.17e-06200616M9341
CoexpressionDESCARTES_ORGANOGENESIS_EPENDYMAL_CELL

CFAP47 POTEM POTEG POTEB2 POTEH POTEB

4.97e-05282616MM3642
CoexpressionDARWICHE_PAPILLOMA_PROGRESSION_RISK

POTEM POTEB2 POTEH POTEB

6.36e-0592614MM503
CoexpressionYAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN

POTEM MYOM2 POTEB2 POTEH POTEB RYR2

8.23e-05309616MM1244
ToppCellMS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class

ZNF385D SPTLC3 ACSM3 SCN9A MINAR1 CCDC171

3.15e-071996163384db80f6024bcabe2625f24d5f4e0d3d8caa7e
ToppCellCOVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class

ZNF385D SPTLC3 ACSM3 OSBPL1A SCN9A CCDC171

3.15e-0719961625de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCellnormal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

ZNF385D TGFBR3 ATRIP NFIL3 L1TD1

3.75e-06171615f49dfe11ae66d82125b577c48345a13683d7bb7b
ToppCellCOVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class

ZNF385D SPTLC3 OSBPL1A SCN9A CCDC171

5.21e-061836154146b1c0e5f76d25226745abfa28f77127a444fc
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A MINAR1 CPED1

5.21e-06183615d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF385D SPTLC3 TGFBR3 CPED1 RYR2

5.21e-061836157eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellCOVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class

ZNF385D SPTLC3 OSBPL1A SCN9A CCDC171

5.21e-0618361592aab7ce65aca17988bc2add4ff9fb8384e2c21b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF385D TGFBR3 ACSM3 CCDC171 CPED1

5.50e-061856156712512100ccef456d2e2bd201d0987986c92ac9
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF385D TGFBR3 ACSM3 CPED1 RYR2

5.94e-061886153177b2c1723268d330d3e9f24f9e24492ace6286
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF385D TGFBR3 ACSM3 CPED1 RYR2

5.94e-06188615293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCellCOVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass

ZNF385D SPTLC3 OSBPL1A SCN9A CCDC171

6.10e-061896152157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCellCOVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class

ZNF385D SPTLC3 ACSM3 OSBPL1A CCDC171

6.10e-0618961596015439971e2e5b8d6294ca5a6b873c7774e925
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9

POTEE POTEM POTEF POTEH

7.16e-069061496e836c7a1df279ac812b7c3aa75e6b81b614244
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CCDC171 CPED1

7.83e-0619961538cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-gd_T|Int-URO / Disease, condition lineage and cell class

TGFBR3 HOXC5 BCL11B ZBED2 RYR2

8.02e-06200615d382ee690e370886009eff42d14952d44a6d4d18
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 MINAR1 CPED1

8.02e-0620061509537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1 RYR2

8.02e-062006158988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells)

ZNF14 BCL11B ZBED2 CHGB

5.77e-05153614cda759ab83a271974651fe4faa21ed4f7ecbb3ae
ToppCellCOVID-19_Moderate-multiplets|World / disease group, cell group and cell class

POTEE TGFBR3 BCL11B MYOM2

6.22e-05156614afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCellClub_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id

FIBCD1 KDR MINAR1 CHGB

7.55e-051646144e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCellTCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9

POTEE POTEF POTEG

8.89e-0563613d7dc1356a60cb527fe668328d5375f352239d911
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

9.71e-0517561411f49f00e000cbc137e3540a6d6805cde21d96e6
ToppCellInt-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type

HOXC5 BCL11B ZBED2 RYR2

9.92e-0517661415016a73c953d8d3e7c32a05ead5e7261f9914ca
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 ZNF385D MINAR1 CPED1

1.01e-041776142b675840b7d2bb536c2c600936733bd9e97e7120
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CFAP47 ACSM3 MINAR1 CPED1

1.01e-041776145e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D TGFBR3 SCN9A CPED1

1.04e-041786146ad46b0720298bcb927fd53468bb4ea0c199ad35
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.06e-041796143b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCellFF-Differ-KC|World / shred by cell class for mouse tongue

OSBPL1A FIBCD1 MYOM2 PMFBP1

1.06e-041796141526a130565a97c291a25a7a988089bffc1515c1
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A MINAR1

1.11e-04181614bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.11e-041816147704f236831cffe4f2a75d4c461eb88b4177e206
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.11e-04181614153709b4dd3d81e09f251fa8765b58bed1932fda
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Cplx3-Hs6st2_(Entorhinal_cortex)|Hippocampus / BrainAtlas - Mouse McCarroll V32

MYH3 L1TD1 PMFBP1

1.12e-046861375e81b353ef313d5e98d5c98d584335f1d1fa658
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Cplx3-Hs6st2_(Entorhinal_cortex)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

MYH3 L1TD1 PMFBP1

1.12e-046861301ba0ccc5732189a5c0c32cb7819289102711b93
ToppCell21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class

CFAP47 FIBCD1 CCDC171 CCDC40

1.13e-041826146e35892fa959ee31591850ded8f1088195ddeb01
ToppCellPBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-04184614a6169613c6493b947a176493f542368bfa935dab
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-0418461451d0447699e3b8f01abbde83f26b748bc9f3c723
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-04184614f7b0bb45a9055ab34e98b251217f6ec38c75ca22
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

MYOM2 CPED1 RYR2 LRRFIP2

1.18e-04184614ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D TGFBR3 SCN9A CPED1

1.18e-041846147d41784eac0935e77d6bc701f20c693adf998730
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-04184614cc01c19180861f491a8dc16d60fabd1215fc4525
ToppCellPBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-04184614492c680f0769ba4e651d09c2e8e5d5d271ed08aa
ToppCellPBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZNF385D SPTLC3 SCN9A CCDC171

1.18e-0418461426edbf84216538b80f1ffcc079ee6e385a71fbf9
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D TGFBR3 BCL11B SCN9A

1.20e-04185614e87e6e097dc29ece8aea671935bde281b99b93ea
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

MYOM2 CPED1 RYR2 LRRFIP2

1.20e-041856146baccb26f999145e51b91d94315bf8d4655bef31
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D SCN9A MINAR1 CPED1

1.20e-04185614f4ac62009c0ad3346e71b809e17727303c4df153
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D TGFBR3 BCL11B KDR

1.23e-0418661477592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ZNF385D SPTLC3 FIBCD1 CPED1

1.25e-04187614387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 FIBCD1 CHGB RYR2

1.25e-04187614e04a84989d624378141042768383b9c846901f2d
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 FIBCD1 CHGB RYR2

1.25e-0418761424cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 FIBCD1 CHGB RYR2

1.25e-041876142f153b203fe79f206319603cf94d3a03ab49a05d
ToppCellCOVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type

ZNF385D MYOM2 CPED1 RYR2

1.33e-04190614918ad5037881212008f9f69d5df5da91fd01422c
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.33e-041906143f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

ZNF385D BCL11B SCN9A RYR2

1.33e-041906146e92c78799f34b31d098854503c796edb0dc7f80
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D SCN9A MINAR1 CPED1

1.33e-04190614305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A MINAR1

1.33e-04190614e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

MYOM2 CPED1 RYR2 LRRFIP2

1.39e-04192614ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

HIVEP2 NFIL3 UBR4 NUP98

1.39e-041926146bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D TGFBR3 SCN9A CPED1

1.39e-041926140003d7ef9a8e521e70ac33c63aad843d9b6215c2
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.41e-041936144979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D SCN9A MINAR1 CPED1

1.41e-0419361453bcd50892c379b2a571751f6eb1062436339fe7
ToppCellLA-14._Fibroblast_III|LA / Chamber and Cluster_Paper

TGFBR3 ACSM3 HIVEP2 NFIL3

1.41e-041936147426c291bac59e539c427bcaae18abc7d397d44e
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D BCL11B SCN9A CPED1

1.41e-04193614c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF385D SCN9A MINAR1 CPED1

1.41e-041936145581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCellLA-14._Fibroblast_III|World / Chamber and Cluster_Paper

TGFBR3 ACSM3 HIVEP2 NFIL3

1.44e-04194614803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ZNF385D CPED1 SKAP2 LRRFIP2

1.47e-04195614c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF385D MYOM2 CPED1 RYR2

1.50e-041966149830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF385D MYOM2 CPED1 RYR2

1.53e-04197614ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellSepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class

TGFBR3 HOXC5 BCL11B RYR2

1.56e-04198614c53405a8d082fbd10131a6ec88b69fdd835f2925
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF385D MYOM2 CPED1 RYR2

1.56e-04198614c12e7511628db819a52959bb68580e27c00c2e41
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF385D MYOM2 CPED1 RYR2

1.56e-0419861422e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCellCOVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class

ZNF385D ACSM3 SCN9A CCDC171

1.59e-041996140230103c37ae3aff58240739b89f2c36b1e39a69
ToppCellcontrol-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ACSM3 NFIL3 CCDC138 L1TD1

1.59e-041996145db7c8089172ac8e796613b3cef618d87007a0ab
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D SCN9A MINAR1 CPED1

1.62e-042006143cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D TGFBR3 SCN9A CPED1

1.62e-042006144a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TGFBR3 NFIL3 KDR CPED1

1.62e-04200614a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D SCN9A MINAR1 CPED1

1.62e-0420061497a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1

1.62e-0420061487827041663013f5e7273168dc8709d69840e7ce
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D BCL11B SCN9A CPED1

1.62e-04200614c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D SCN9A MINAR1 CPED1

1.62e-042006148ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1

1.62e-04200614593bf6a7c557437db9a9249a5058a46014179ef6
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1

1.62e-0420061408bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D SCN9A MINAR1 CPED1

1.62e-04200614107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ZNF385D TGFBR3 ZNF385B CPED1

1.62e-04200614c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1

1.62e-04200614a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 ACSM3 CPED1

1.62e-0420061402cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D TGFBR3 SCN9A CPED1

1.62e-04200614fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D TGFBR3 SCN9A CPED1

1.62e-04200614c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.

OSBPL1A SCN9A ZNF385B RYR2

1.62e-042006145c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCellLPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type

ZNF385D TGFBR3 CPED1 RYR2

1.62e-042006148bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D BCL11B SCN9A CPED1

1.62e-04200614117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCellNeuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic

ZNF385D BCL11B SCN9A CPED1

1.62e-04200614d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCellTCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9

POTEM POTEG POTEH

3.00e-049561348ad5d89ee9a1941d1d3dbdbfb03893a390c0d64
ToppCellTCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9

POTEM POTEG POTEH

3.10e-04966134cca2f5e754b82075740adaa0a147d16368be908
Diseasespecific language impairment, dyslexia

ZFP64 PMFBP1

1.84e-0412502EFO_0005424, EFO_1001510
Diseaseairway wall thickness measurement

ZNF385D BCL11B

1.84e-0412502EFO_0006898
DiseaseFEV/FEC ratio

MED15 TGFBR3 AMPD3 HOXC5 HIVEP2 CTCF KDR CCDC171 SKAP2

1.95e-041228509EFO_0004713
Diseasemale infertility (implicated_via_orthology)

CFAP47 PMFBP1

2.17e-0413502DOID:12336 (implicated_via_orthology)
Diseasebirth weight

AMPD3 BCL11B HIVEP2 NFIL3 CCDC138

5.67e-04399505EFO_0004344
Diseaseneuroblastoma

ZFP64 L1TD1 ZNF385B

1.01e-03116503EFO_0000621
Diseaseselenium measurement

ZNF14 MYOM2

1.11e-0329502EFO_0006331
Diseaseserum IgG glycosylation measurement

ZNF385D BCL11B HIVEP2 RYR2 CCDC40

1.89e-03523505EFO_0005193
Diseaseforced expiratory volume

MED15 AMPD3 KDR SKAP2 RYR2 PMFBP1

2.09e-03789506EFO_0004314
Diseaseulcerative colitis (is_marker_for)

ACSM3 KDR

2.11e-0340502DOID:8577 (is_marker_for)
Diseasedyslexia

BCL11B HEATR5B CCDC171

2.64e-03162503EFO_0005424
Diseasesystolic blood pressure change measurement

TGFBR3 BCL11B

2.90e-0347502EFO_0006944
DiseaseMyocardial Ischemia

HIVEP2 KDR RYR2

3.33e-03176503C0151744
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

AMPD3 ZC3H4 CCDC171 PMFBP1

3.35e-03364504EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946

Protein segments in the cluster

PeptideGeneStartEntry
AHNSGTKHKTMLEAR

ZNF385D

221

Q9H6B1
SGDDLSAKKSRHDSM

DCUN1D4

71

Q92564
DSLDSKDPKHSHMKA

CNTRL

541

Q7Z7A1
LDRHMKSHTDERPHK

CTCF

281

P49711
TRKVKESMETHFGSH

CPED1

81

A4D0V7
EKEMTSHRSHIAALK

CCDC171

1221

Q6TFL3
VDDESKHSDHMFSDK

AMPD3

526

Q01432
SGDHDDSFMKTLRSK

POTEB2

46

H3BUK9
AKLEMVHKSRKDHSS

PALM2

241

Q8IXS6
HKSKSEEAHAEDSVM

SERBP1

326

Q8NC51
SGDHDDSAMKTLRSK

POTEF

46

A5A3E0
KLHMSHETDGKRSRT

HOXC5

146

Q00444
IHEAKAVRAHMESDK

NUP98

1616

P52948
ESTAAAEHKGKIIMH

PCK2

481

Q16822
KHDSHMAKERAHSTA

PDZK1P1

376

A8MUH7
DMTSKRHFELEKHSA

NFIL3

356

Q16649
GVAHSKSSKDMESHV

MED15

31

Q96RN5
KNLSTSEGVSKEMHH

KRIT1

606

O00522
HLGSRKHRMSEEKDC

OSBPL1A

506

Q9BXW6
SHGMKKRSSDSHKDL

LRRFIP2

131

Q9Y608
AKKIREEEMCHHSSS

POM121B

36

A6NF01
SGDHDDSFMKTLRSK

POTEB3

46

A0JP26
KDEHMKSSEHRLAGS

PCF11

431

O94913
ILKMRSTEGHHKAFS

OR5P2

221

Q8WZ92
SGDHDDSAMKTLRSK

POTEE

46

Q6S8J3
FAEKDEHTGIHTMKL

FAM9A

106

Q8IZU1
KAHGAHLKASAAMVR

HEATR5B

656

Q9P2D3
THMHKAGSLAGRSDD

BCL11B

476

Q9C0K0
RLKGSSHAVHEMKSL

CCDC138

321

Q96M89
SSLVGMKHRDEAHRA

CCDC40

501

Q4G0X9
KHSGMRFTTKDRDSD

FIBCD1

381

Q8N539
VSSDHKVHRLLDGMS

ATRIP

81

Q8WXE1
VSMASLGEKRDHHST

CHGB

316

P05060
GVISKRDFHKAMESH

RYR2

4041

Q92736
AKAKIDATHKTHDNM

CFAP47

3141

Q6ZTR5
HMHSKEGRKKAFTTI

OR2L13

226

Q8N349
GKYSDRHTMKHSDDD

MINAR1

496

Q9UPX6
AKLSGEKDHLHSVMV

PMFBP1

916

Q8TBY8
IGHTVNKMRKHSDSE

TCEANC2

81

Q96MN5
EGEHMLSKAFQSHLK

SYNJ1

306

O43426
KMSQDSVHHTSGDKS

SKAP2

281

O75563
SGDHDDSFMKTLRSK

POTEB

46

A0A0A6YYL3
HTLAEMSKGHNFLKE

SCN9A

1041

Q15858
HEAMVAALRKKHADS

MYH3

1186

P11055
ASTRHEMGTLDKHKE

SPTLC3

196

Q9NUV7
GNLKELMKHASDSHT

ACSM3

206

Q53FZ2
HLKSMHREELEKSGH

ZBED2

101

Q9BTP6
HGVLTRKTHADMDGK

PSD2

516

Q9BQI7
DDAKVHKMFLDHTGS

VPS18

96

Q9P253
EAHNTGSKHKTMVEA

ZNF385B

301

Q569K4
RSRKEKGEKHHSDSD

ZC3H4

81

Q9UPT8
AVKMLKEGATHSEHR

KDR

866

P35968
KEGATHSEHRALMSE

KDR

871

P35968
LEDLHKAAEKHSMSS

HIVEP2

1876

P31629
DHLIKQGMKAEHASS

UBR4

1056

Q5T4S7
DEHFSKMAAETDPHK

UBR4

1136

Q5T4S7
SGDHDDSAMKTLRSK

POTEG

46

Q6S5H5
SGDHDDSAMKTLRSK

POTEH

46

Q6S545
SGDHDDSAMKTLRSK

POTEM

46

A6NI47
SSDLKRHMIVHSGEK

ZFP64

426

Q9NTW7
HHEAESKEKGPSMKE

TGFBR3

756

Q03167
SSKFRMHERTHTGEK

ZNF14

571

P17017
ASPSKSLEMSHDEHK

L1TD1

556

Q5T7N2
HKDAKISSSEHMRIG

MYOM2

1266

P54296